Correlation of laterally spreading type and JC virus with methylator phenotype status in colorectal adenoma

Katsuhiko Nosho, Hiroyuki Yamamoto, Taiga Takahashi, Masashi Mikami, Keiichi Hizaki, Tadateru Maehata, Hiroaki Taniguchi, Satoshi Yamaoka, Yasushi Adachi, Fumio Itoh, Kohzoh Imai, Yasuhisa Shinomura

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Accurate frequencies of CpG island methylator phenotype (CIMP) have not been determined for laterally spreading tumors (LSTs) and other flat-type colorectal adenomas, and the role of JC virus T-antigen (T-Ag) in these tumors is unclear. We used MethyLight assay to analyze the relationship between CIMP status and clinicopathologic characteristics in tissue from 72 LST of granular-type (LST-G), 35 LST of nongranular-type (LST-NG), 54 protruded-type adenomas, and 89 colorectal cancers. We also investigated the relationship between CIMP status and T-Ag by immunohistochemistry. With the use of 5 markers for CIMP status, tumors were classified as CIMP-high (≥4/5 methylated promoters), CIMP-low (1/5 to 3/5 methylated promoters), or CIMP-0 (no methylated promoters). The proportion classified as CIMP-0 status was 5.6% for protruded-type adenoma, 17.1% for LST-NG, and 29.2% for LST-G (LST-G versus protruded-type adenoma, P = .001). CIMP-low status was established for 62.5% of LST-G, 74.3% of LST-NG, and 81.5% of protruded-type adenomas. CIMP-high status was established for 8.3% of LST-G, 8.6% of LST-NG, and 12.9% of protruded-type adenomas. The proportions of CIMP-low and CIMP-high status were not significantly different between the 3 groups. Multiple logistic analysis showed that LST-G appearance was the only significant factor for identifying CIMP-0 status. BRAF mutation was the only significant factor for identifying CIMP-high status. T-Ag expression increased with CIMP status and was not associated with macroscopic appearance. In conclusion, among colorectal adenomas, CIMP-high status was determined by BRAF mutation and not by macroscopic type, unlike CIMP-0. JC virus T-Ag may be important in determining methylator phenotype.

Original languageEnglish
Pages (from-to)767-775
Number of pages9
JournalHuman Pathology
Volume39
Issue number5
DOIs
Publication statusPublished - 2008 May
Externally publishedYes

Fingerprint

JC Virus
CpG Islands
Adenoma
Phenotype
Neoplasms
Viral Tumor Antigens

Keywords

  • BRAF
  • CIMP
  • Colorectal adenoma
  • JC virus
  • LST

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Correlation of laterally spreading type and JC virus with methylator phenotype status in colorectal adenoma. / Nosho, Katsuhiko; Yamamoto, Hiroyuki; Takahashi, Taiga; Mikami, Masashi; Hizaki, Keiichi; Maehata, Tadateru; Taniguchi, Hiroaki; Yamaoka, Satoshi; Adachi, Yasushi; Itoh, Fumio; Imai, Kohzoh; Shinomura, Yasuhisa.

In: Human Pathology, Vol. 39, No. 5, 05.2008, p. 767-775.

Research output: Contribution to journalArticle

Nosho, K, Yamamoto, H, Takahashi, T, Mikami, M, Hizaki, K, Maehata, T, Taniguchi, H, Yamaoka, S, Adachi, Y, Itoh, F, Imai, K & Shinomura, Y 2008, 'Correlation of laterally spreading type and JC virus with methylator phenotype status in colorectal adenoma', Human Pathology, vol. 39, no. 5, pp. 767-775. https://doi.org/10.1016/j.humpath.2007.10.005
Nosho, Katsuhiko ; Yamamoto, Hiroyuki ; Takahashi, Taiga ; Mikami, Masashi ; Hizaki, Keiichi ; Maehata, Tadateru ; Taniguchi, Hiroaki ; Yamaoka, Satoshi ; Adachi, Yasushi ; Itoh, Fumio ; Imai, Kohzoh ; Shinomura, Yasuhisa. / Correlation of laterally spreading type and JC virus with methylator phenotype status in colorectal adenoma. In: Human Pathology. 2008 ; Vol. 39, No. 5. pp. 767-775.
@article{a7133eee04214eecbf9a3b7a55b82ed4,
title = "Correlation of laterally spreading type and JC virus with methylator phenotype status in colorectal adenoma",
abstract = "Accurate frequencies of CpG island methylator phenotype (CIMP) have not been determined for laterally spreading tumors (LSTs) and other flat-type colorectal adenomas, and the role of JC virus T-antigen (T-Ag) in these tumors is unclear. We used MethyLight assay to analyze the relationship between CIMP status and clinicopathologic characteristics in tissue from 72 LST of granular-type (LST-G), 35 LST of nongranular-type (LST-NG), 54 protruded-type adenomas, and 89 colorectal cancers. We also investigated the relationship between CIMP status and T-Ag by immunohistochemistry. With the use of 5 markers for CIMP status, tumors were classified as CIMP-high (≥4/5 methylated promoters), CIMP-low (1/5 to 3/5 methylated promoters), or CIMP-0 (no methylated promoters). The proportion classified as CIMP-0 status was 5.6{\%} for protruded-type adenoma, 17.1{\%} for LST-NG, and 29.2{\%} for LST-G (LST-G versus protruded-type adenoma, P = .001). CIMP-low status was established for 62.5{\%} of LST-G, 74.3{\%} of LST-NG, and 81.5{\%} of protruded-type adenomas. CIMP-high status was established for 8.3{\%} of LST-G, 8.6{\%} of LST-NG, and 12.9{\%} of protruded-type adenomas. The proportions of CIMP-low and CIMP-high status were not significantly different between the 3 groups. Multiple logistic analysis showed that LST-G appearance was the only significant factor for identifying CIMP-0 status. BRAF mutation was the only significant factor for identifying CIMP-high status. T-Ag expression increased with CIMP status and was not associated with macroscopic appearance. In conclusion, among colorectal adenomas, CIMP-high status was determined by BRAF mutation and not by macroscopic type, unlike CIMP-0. JC virus T-Ag may be important in determining methylator phenotype.",
keywords = "BRAF, CIMP, Colorectal adenoma, JC virus, LST",
author = "Katsuhiko Nosho and Hiroyuki Yamamoto and Taiga Takahashi and Masashi Mikami and Keiichi Hizaki and Tadateru Maehata and Hiroaki Taniguchi and Satoshi Yamaoka and Yasushi Adachi and Fumio Itoh and Kohzoh Imai and Yasuhisa Shinomura",
year = "2008",
month = "5",
doi = "10.1016/j.humpath.2007.10.005",
language = "English",
volume = "39",
pages = "767--775",
journal = "Human Pathology",
issn = "0046-8177",
publisher = "W.B. Saunders Ltd",
number = "5",

}

TY - JOUR

T1 - Correlation of laterally spreading type and JC virus with methylator phenotype status in colorectal adenoma

AU - Nosho, Katsuhiko

AU - Yamamoto, Hiroyuki

AU - Takahashi, Taiga

AU - Mikami, Masashi

AU - Hizaki, Keiichi

AU - Maehata, Tadateru

AU - Taniguchi, Hiroaki

AU - Yamaoka, Satoshi

AU - Adachi, Yasushi

AU - Itoh, Fumio

AU - Imai, Kohzoh

AU - Shinomura, Yasuhisa

PY - 2008/5

Y1 - 2008/5

N2 - Accurate frequencies of CpG island methylator phenotype (CIMP) have not been determined for laterally spreading tumors (LSTs) and other flat-type colorectal adenomas, and the role of JC virus T-antigen (T-Ag) in these tumors is unclear. We used MethyLight assay to analyze the relationship between CIMP status and clinicopathologic characteristics in tissue from 72 LST of granular-type (LST-G), 35 LST of nongranular-type (LST-NG), 54 protruded-type adenomas, and 89 colorectal cancers. We also investigated the relationship between CIMP status and T-Ag by immunohistochemistry. With the use of 5 markers for CIMP status, tumors were classified as CIMP-high (≥4/5 methylated promoters), CIMP-low (1/5 to 3/5 methylated promoters), or CIMP-0 (no methylated promoters). The proportion classified as CIMP-0 status was 5.6% for protruded-type adenoma, 17.1% for LST-NG, and 29.2% for LST-G (LST-G versus protruded-type adenoma, P = .001). CIMP-low status was established for 62.5% of LST-G, 74.3% of LST-NG, and 81.5% of protruded-type adenomas. CIMP-high status was established for 8.3% of LST-G, 8.6% of LST-NG, and 12.9% of protruded-type adenomas. The proportions of CIMP-low and CIMP-high status were not significantly different between the 3 groups. Multiple logistic analysis showed that LST-G appearance was the only significant factor for identifying CIMP-0 status. BRAF mutation was the only significant factor for identifying CIMP-high status. T-Ag expression increased with CIMP status and was not associated with macroscopic appearance. In conclusion, among colorectal adenomas, CIMP-high status was determined by BRAF mutation and not by macroscopic type, unlike CIMP-0. JC virus T-Ag may be important in determining methylator phenotype.

AB - Accurate frequencies of CpG island methylator phenotype (CIMP) have not been determined for laterally spreading tumors (LSTs) and other flat-type colorectal adenomas, and the role of JC virus T-antigen (T-Ag) in these tumors is unclear. We used MethyLight assay to analyze the relationship between CIMP status and clinicopathologic characteristics in tissue from 72 LST of granular-type (LST-G), 35 LST of nongranular-type (LST-NG), 54 protruded-type adenomas, and 89 colorectal cancers. We also investigated the relationship between CIMP status and T-Ag by immunohistochemistry. With the use of 5 markers for CIMP status, tumors were classified as CIMP-high (≥4/5 methylated promoters), CIMP-low (1/5 to 3/5 methylated promoters), or CIMP-0 (no methylated promoters). The proportion classified as CIMP-0 status was 5.6% for protruded-type adenoma, 17.1% for LST-NG, and 29.2% for LST-G (LST-G versus protruded-type adenoma, P = .001). CIMP-low status was established for 62.5% of LST-G, 74.3% of LST-NG, and 81.5% of protruded-type adenomas. CIMP-high status was established for 8.3% of LST-G, 8.6% of LST-NG, and 12.9% of protruded-type adenomas. The proportions of CIMP-low and CIMP-high status were not significantly different between the 3 groups. Multiple logistic analysis showed that LST-G appearance was the only significant factor for identifying CIMP-0 status. BRAF mutation was the only significant factor for identifying CIMP-high status. T-Ag expression increased with CIMP status and was not associated with macroscopic appearance. In conclusion, among colorectal adenomas, CIMP-high status was determined by BRAF mutation and not by macroscopic type, unlike CIMP-0. JC virus T-Ag may be important in determining methylator phenotype.

KW - BRAF

KW - CIMP

KW - Colorectal adenoma

KW - JC virus

KW - LST

UR - http://www.scopus.com/inward/record.url?scp=42649086015&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42649086015&partnerID=8YFLogxK

U2 - 10.1016/j.humpath.2007.10.005

DO - 10.1016/j.humpath.2007.10.005

M3 - Article

C2 - 18284934

AN - SCOPUS:42649086015

VL - 39

SP - 767

EP - 775

JO - Human Pathology

JF - Human Pathology

SN - 0046-8177

IS - 5

ER -